ctDNA Tracking May Guide Adjuvant Chemotherapy After Liver Metastasis Surgery

◆ TRIAL DATA

The phase II GALAXY study showed that circulating tumor DNA monitoring for molecular residual disease could help identify which patients with colorectal cancer liver metastases are most likely to benefit from chemotherapy after surgery. (The ASCO Post, ESMO GI Congress 2026)